China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.

Social media posts claimed that the logo of a biotech lab in Wuhan, the Chinese city at the center of the January 2020 outbreak, was eerily similar to the logo of the Umbrella Corporation.

Genuine Biotech, headquartered in Pingdingshan, applied for regulatory approval earlier this month. In an announcement, the company said that 40% of people with COVID-19 who were given Azvudine ...

Chinese regulators authorized an HIV treatment developed by a domestic firm Genuine Biotech to treat certain patients with COVID-19 on Monday, adding another tool for the country’s ...